(18)F-Fluorodeoxyglucose PET-CT evaluation after one course of neoadjuvant therapy fails to predict pCR in HER2 + BC patients: a prospective and multicentric French study
一项前瞻性多中心法国研究表明,新辅助治疗一个疗程后进行 (18)F-氟代脱氧葡萄糖 PET-CT 评估无法预测 HER2 阳性乳腺癌患者的病理完全缓解 (pCR)。
期刊:Breast Cancer Research
影响因子:5.6
doi:10.1186/s13058-025-02156-w
Chanchou, M; Mouret-Reynier, M A; Molnar, I; Deshayes, E; D'Hondt, V; Bourahla, K; Petit, T; Bardet, S; Levy, C; Morel, O; Augereau, P; Rousseau, C; Campone, M; Monteil, J; Venat-Bouvet, L; Faye, A; Benavent, V; Cachin, F